Sec. 5861. Prioritization of efforts of the Department of State to combat international trafficking in covered synthetic drugs
1,017 words·~5 min read·
/bill/117/hr/7900/pcs/section-5861A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Secretary of State shall prioritize efforts of the Department of State to combat international trafficking in covered synthetic drugs by carrying out programs and activities including the following: Supporting increased data collection by the United States and foreign countries through increased drug use surveys among populations, increased use of wastewater testing where appropriate, and multilateral sharing of that data. Engaging in increased consultation and partnership with international drug agencies, including the European Monitoring Centre for Drugs and Drug Addiction, and regulatory agencies in foreign countries.
Carrying out the program to provide assistance to build the capacity of foreign law enforcement agencies with respect to covered synthetic drugs. Carrying out exchange programs for governmental and nongovernmental personnel in the United States and in foreign countries to provide educational and professional development on demand reduction matters relating to the illicit use of narcotics and other drugs. Not later than one year after the date of the enactment of this Act, the Secretary of State shall submit to the appropriate congressional committees a report on the implementation of this section.
In this subsection, the term appropriate congressional committees means— the Committee on Foreign Affairs and the Committee on Appropriations of the House of Representatives; and the Committee on Foreign Relations and the Committee on Appropriations of the Senate. Notwithstanding section 660 of the Foreign Assistance Act of 1961 ( 22 U.S.C. 2420 ), the Secretary of State shall establish a program to provide assistance to build the capacity of law enforcement agencies of the countries described in paragraph
(3)to help such agencies to identify, track, and improve their forensics detection capabilities with respect to covered synthetic drugs. The Secretary of State shall prioritize assistance under paragraph
(1)among those countries described in paragraph
(3)in which such assistance would have the most impact in reducing illicit use of covered synthetic drugs in the United States. The foreign countries described in this paragraph are— countries that are producers of covered synthetic drugs; countries whose pharmaceutical and chemical industries are known to be exploited for development or procurement of precursors of covered synthetic drugs; or major drug-transit countries as defined by the President. In addition to amounts otherwise authorized for the purposes described in this subsection, there is authorized to be appropriated to the Secretary $4,000,000 for each of the fiscal years 2023 through 2027 to carry out this subsection. The Secretary of State shall establish or continue and strengthen, as appropriate, an exchange program for governmental and nongovernmental personnel in the United States and in foreign countries to provide educational and professional development on demand reduction matters relating to the illicit use of narcotics and other drugs. The program required by paragraph (1)— shall be limited to individuals who have expertise and experience in matters described in paragraph (1); in the case of inbound exchanges, may be carried out as part of exchange programs and international visitor programs administered by the Bureau of Educational and Cultural Affairs of the Department of State, including the International Visitor Leadership Program in consultation or coordination with the Bureau of International Narcotics and Law Enforcement Affairs; and shall include outbound exchanges for governmental or nongovernmental personnel in the United States. In addition to amounts otherwise authorized for the purposes described in this subsection, there is authorized to be appropriated to the Secretary $1,000,000 for each of the fiscal years 2023 through 2027 to carry out this subsection. Section 489(a) of the Foreign Assistance Act of 1961 ( 22 U.S.C. 2291h(a) ) is amended— by redesignating the second paragraph
(10)(relating to an identification of the countries that are the most significant sources of illicit fentanyl and fentanyl analogues) as paragraph (11); and by adding at the end the following: Information that contains an assessment of the countries significantly involved in the manufacture, production, or transshipment of synthetic opioids, including fentanyl and fentanyl analogues, including the following: The scale of legal domestic production and any available information on the number of manufacturers and producers of such opioids in such countries. Information on any law enforcement assessments of the scale of illegal production, including a description of the capacity of illegal laboratories to produce such opioids. The types of inputs used and a description of the primary methods of synthesis employed by illegal producers of such opioids. An assessment of the policies of such countries to regulate licit manufacture and interdict illicit manufacture, diversion, distribution, and shipment of such opioids and an assessment of the effectiveness of the policies' implementation. Information on, to the extent practicable, any policies of responding to a substance described in section __ (g)(2) of the National Defense Authorization Act for Fiscal Year 2023, including the following: Which governments have articulated policies on scheduling of such substances. Any data on impacts of such policies and other responses to such substances. An assessment of any policies the United States could adopt to improve its response to such substances. . Section 481(e) of the Foreign Assistance Act of 1961 ( 22 U.S.C. 2291(e) ) is amended— in paragraph (2)(D), by inserting or a significant direct source of illicit narcotic or psychotropic drugs or other controlled substances after opioids ; and by amending paragraph
(5)to read as follows: the term major drug-transit country means a country through which are transported illicit narcotic or psychotropic drugs or other controlled substances significantly affecting the United States. . In this section, the term covered synthetic drug means— a synthetic controlled substance (as defined in section 102(6) of the Controlled Substances Act ( 21 U.S.C. 802(6) )), including fentanyl or a fentanyl analogue; or a substance of abuse, or any preparation thereof, that— is not— included in any schedule as a controlled substance under the Controlled Substances Act ( 21 U.S.C. 801 et seq. ); or controlled by the Single Convention on Narcotic Drugs signed at New York, New York, on March 30, 1961, or the Convention on Psychotropic Substances signed at Vienna, Austria, on February 21, 1971; is new or has reemerged on the illicit market; and poses a threat to the public health and safety.
Connectionstraces to 5
Citation graph
cites case law
Sec. 5861
Prioritization of efforts of the Department of State to combat international trafficking in covered synthetic drugs
Cites 5Cited by 0 across 0 sources